Assessment of cardiovascular events in a real-world high-risk cohort with type 2 diabetes or atheroscleortic cardiovascular disease in Germany

被引：0
|
作者：
Verket, M. [1 ]
Kossack, N. [2 ]
Brandts, J. [1 ]
Schoenfelder, T. [2 ,3 ]
Schuett, K. [1 ]
Haeckl, D. [2 ,4 ]
Marx, N. [1 ]
Mueller-Wieland, D. [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Aachen, Germany
[2] WIG2 Sci Inst Hlth Econ & Hlth Syst Res, Leipzig, Germany
[3] Tech Univ Dresden, Med Fac, Chair Hlth Sci Publ Hlth, Dresden, Germany
[4] Univ Leipzig, Fac Econ & Management Sci, Leipzig, Germany
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
876
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [21] Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
    McGuire, D. K.
    Marx, N.
    Mulvagh, S. L.
    Deanfield, J. E.
    Inzucchi, S. E.
    Pop-Busui, R.
    Mann, J. F. E.
    Emerson, S. S.
    Poulter, N. R.
    Engelmann, M. D. M.
    Ripa, M. S.
    Hovingh, G. K.
    Brown-Frandsen, K.
    Bain, S. C.
    Cavender, M. A.
    Gislum, M.
    David, J-P
    Buse, J. B.
    SOUL Study Group
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [22] Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
    Fangel, Mia Vicki
    Nielsen, Peter Bronnum
    Kristensen, Jette Kolding
    Larsen, Torben Bjerregaard
    Overvad, Thure Filskov
    Lip, Gregory Y. H.
    Jensen, Martin Bach
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (06): : E269 - E279
  • [23] REAL-WORLD STATIN UTILIZATION AMONG PATIENTS AT HIGH RISK FOR CARDIOVASCULAR EVENTS: US ANALYSES
    Lin, I
    Sung, J. C.
    Sanchez, R.
    Mallya, U. G.
    Friedman, M.
    Panaccio, M.
    Koren, A.
    Neumann, P. J.
    Menzin, J.
    VALUE IN HEALTH, 2015, 18 (03) : A152 - A152
  • [24] Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database
    Ramirez-Morros, Anna
    Franch-Nadal, Josep
    Real, Jordi
    Gratacos, Monica
    Mauricio, Didac
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [25] The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
    McGurnaghan, Stuart J.
    Brierley, Liam
    Caparrotta, Thomas M.
    McKeigue, Paul M.
    Blackbourn, Luke A. K.
    Wild, Sarah H.
    Leese, Graham P.
    McCrimmon, Rory J.
    McKnight, John A.
    Pearson, Ewan R.
    Petrie, John R.
    Sattar, Naveed
    Colhoun, Helen M.
    DIABETOLOGIA, 2019, 62 (04) : 621 - 632
  • [26] The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study
    Stuart J. McGurnaghan
    Liam Brierley
    Thomas M. Caparrotta
    Paul M. McKeigue
    Luke A. K. Blackbourn
    Sarah H. Wild
    Graham P. Leese
    Rory J. McCrimmon
    John A. McKnight
    Ewan R. Pearson
    John R. Petrie
    Naveed Sattar
    Helen M. Colhoun
    Diabetologia, 2019, 62 : 621 - 632
  • [27] Real-world burden of severe hypoglycaemic events in type 1 diabetes in Germany
    Ziegler, R.
    Zhang, Q.
    Callahan, P.
    Vetter, C.
    Garal-Pantaler, E.
    De Remigis, A.
    Chen, L.
    Rathmann, W.
    DIABETOLOGIA, 2024, 67 : S57 - S57
  • [28] Real-world effectiveness and safety of evolocumab in very high-risk atherosclerotic cardiovascular disease patients with acute ischemic stroke
    Ting Zhang
    Yajing Zhang
    Yun Yang
    Haibing Liao
    Xun Li
    Ran Liu
    Xueqing Liu
    Liqin Yang
    Wei Yue
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 302 - 311
  • [29] Real-world effectiveness and safety of evolocumab in very high-risk atherosclerotic cardiovascular disease patients with acute ischemic stroke
    Zhang, Ting
    Zhang, Yajing
    Yang, Yun
    Liao, Haibing
    Li, Xun
    Liu, Ran
    Liu, Xueqing
    Yang, Liqin
    Yue, Wei
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (02) : 302 - 311
  • [30] Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk
    Dilidaer Muhanhali
    Tianyu Zhai
    Zhenqin Cai
    Yan Ling
    Endocrine, 2020, 69 : 63 - 72
12345